دورية أكاديمية
أعرض في EDS

Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models.

التفاصيل البيبلوغرافية
العنوان: Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models.
المؤلفون: Seyoum D; Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels B-1082, Belgium. dinberu.seyoum@gmail.com.; Department of Statistics, Natural Science College, Jimma University, Jimma, PO Box 378, Ethiopia. dinberu.seyoum@gmail.com., Degryse JM; Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels B-1082, Belgium. Jean-Marie.Degryse@uclouvain.be.; Department Public Health and Primary Care, KU Leuven, Leuven B-3000, Belgium. Jean-Marie.Degryse@uclouvain.be., Kifle YG; Department of Statistics and Operations Research, University of Limpopo, Sovenga, 0727, South Africa. yehenew.getachew@yahoo.com., Taye A; School of Mathematical and Statistical Science, Hawassa University, P.O. Box 05, Ethiopia. ayele_taye@yahoo.com., Tadesse M; Department of Medical Laboratory Sciences and Pathology, College of Health Sciences, Jimma University, Jimma, P.O. Box 378, Ethiopia. mulualemt.tadesse@gmail.com., Birlie B; Department of Statistics, Natural Science College, Jimma University, Jimma, PO Box 378, Ethiopia. belaya.birlie@gmail.com., Banbeta A; Department of Statistics, Natural Science College, Jimma University, Jimma, PO Box 378, Ethiopia. akalubanbeta.stat@gmail.com., Rosas-Aguirre A; Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels B-1082, Belgium. angelrosasa@gmail.com.; Institute of Tropical Medicine 'Alexander von Humboldt', Universidad Peruana Cayetano Heredia, Lima 15000, Peru. angelrosasa@gmail.com., Duchateau L; Department of Comparative Physiology and Biometrics, Ghent University, Ghent B-9000, Belgium. luc.duchateau@ugent.be., Speybroeck N; Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels B-1082, Belgium. niko.speybroeck@uclouvain.be.
المصدر: International journal of environmental research and public health [Int J Environ Res Public Health] 2017 Mar 12; Vol. 14 (3). Date of Electronic Publication: 2017 Mar 12.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI, c2004-
مواضيع طبية MeSH: Anti-HIV Agents/*therapeutic use , HIV Infections/*drug therapy , HIV Infections/*mortality, Adult ; Ethiopia/epidemiology ; Female ; Hospitals, University ; Humans ; Male ; Retrospective Studies ; Risk Factors ; Survival Analysis ; Young Adult
مستخلص: Introduction: Efforts have been made to reduce HIV/AIDS-related mortality by delivering antiretroviral therapy (ART) treatment. However, HIV patients in resource-poor settings are still dying, even if they are on ART treatment. This study aimed to explore the factors associated with HIV/AIDS-related mortality in Southwestern Ethiopia. Method: A non-concurrent retrospective cohort study which collected data from the clinical records of adult HIV/AIDS patients, who initiated ART treatment and were followed between January 2006 and December 2010, was conducted, to explore the factors associated with HIV/AIDS-related mortality at Jimma University Specialized Hospital (JUSH). Survival times (i.e., the time from the onset of ART treatment to the death or censoring) and different characteristics of patients were retrospectively examined. A best-fit model was chosen for the survival data, after the comparison between native semi-parametric Cox regression and parametric survival models (i.e., exponential, Weibull, and log-logistic). Result: A total of 456 HIV patients were included in the study, mostly females (312, 68.4%), with a median age of 30 years (inter-quartile range (IQR): 23-37 years). Estimated follow-up until December 2010 accounted for 1245 person-years at risk (PYAR) and resulted in 66 (14.5%) deaths and 390 censored individuals, representing a median survival time of 34.0 months ( IQR: 22.8-42.0 months). The overall mortality rate was 5.3/100 PYAR: 6.5/100 PYAR for males and 4.8/100 PYAR for females. The Weibull survival model was the best model for fitting the data (lowest AIC). The main factors associated with mortality were: baseline age (>35 years old, AHR = 3.8, 95% CI: 1.6-9.1), baseline weight (AHR = 0.93, 95% CI: 0.90-0.97), baseline WHO stage IV (AHR = 6.2, 95% CI: 2.2-14.2), and low adherence to ART treatment (AHR = 4.2, 95% CI: 2.5-7.1). Conclusion: An effective reduction in HIV/AIDS mortality could be achieved through timely ART treatment onset and maintaining high levels of treatment adherence.
References: Epidemiol Health. 2016 Nov 6;38:e2016049. (PMID: 27820957)
Glob Health Action. 2014 Nov 20;7:24826. (PMID: 25416322)
Biometrics. 1978 Mar;34(1):57-67. (PMID: 630037)
AIDS Res Treat. 2015;2015:148769. (PMID: 25821596)
Int Sch Res Notices. 2014 Oct 09;2014:250913. (PMID: 27351014)
BMC Health Serv Res. 2014 Dec 03;14:627. (PMID: 25465206)
Glob Health Action. 2010 Oct 29;3:. (PMID: 21042435)
ISRN AIDS. 2013 Feb 20;2013:491601. (PMID: 24052890)
PLoS One. 2015 May 11;10(5):e0125826. (PMID: 25961732)
PLoS One. 2010 Oct 11;5(10):e13268. (PMID: 20949010)
AIDS Res Treat. 2012;2012:843598. (PMID: 22973505)
BMC Infect Dis. 2014 Jan 14;14:28. (PMID: 24422906)
BMC Public Health. 2014 Aug 11;14:831. (PMID: 25113245)
AIDS. 2005 Nov 18;19(17):2009-18. (PMID: 16260908)
J Int AIDS Soc. 2009 Jun 26;12:9. (PMID: 19558677)
Am J Epidemiol. 1998 Sep 1;148(5):487-96. (PMID: 9737561)
Patient Prefer Adherence. 2015 Oct 29;9:1531-7. (PMID: 26604706)
Pan Afr Med J. 2015 Oct 14;22:138. (PMID: 26889319)
J Korean Med Sci. 2013 Jul;28(7):990-7. (PMID: 23853480)
BMC Infect Dis. 2008 Apr 22;8:52. (PMID: 18430196)
AIDS Res Ther. 2009 Jul 24;6:17. (PMID: 19630949)
East Mediterr Health J. 2011 Mar;17(3):231-7. (PMID: 21735964)
AIDS Res Hum Retroviruses. 2008 Apr;24(4):555-60. (PMID: 18366314)
ISRN AIDS. 2012 Jun 14;2012:721720. (PMID: 24052883)
PLoS Med. 2009 Apr 28;6(4):e1000066. (PMID: 19399157)
Trop Med Int Health. 2009 Jan;14(1):36-43. (PMID: 19017309)
Stat Med. 2002 Aug 15;21(15):2175-97. (PMID: 12210632)
PLoS One. 2014 Jan 31;9(1):e87392. (PMID: 24498093)
Afr J Prim Health Care Fam Med. 2015;7(1):e1-e7. (PMID: 26466398)
Arch Public Health. 2015 Jan 01;73(1):6. (PMID: 25973196)
فهرسة مساهمة: Keywords: Ethiopia; HIV/AIDS; antiretroviral therapy (ART); parametric survival model
المشرفين على المادة: 0 (Anti-HIV Agents)
تواريخ الأحداث: Date Created: 20170314 Date Completed: 20170619 Latest Revision: 20200306
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC5369132
DOI: 10.3390/ijerph14030296
PMID: 28287498
قاعدة البيانات: MEDLINE
الوصف
تدمد:1660-4601
DOI:10.3390/ijerph14030296